Clinical Trial Update: Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of cetuximab and pemetrexed with radiation for head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Alimta (pemetrexed)
• ERBITUX (cetuximab)

Snippet

Sponsor: University of Pittsburgh | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED